Chicago Equity Partners’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-23,035
Closed -$2.29M 1015
2019
Q3
$2.29M Buy
+23,035
New +$2.19M 0.11% 282
2018
Q4
Sell
-50,495
Closed -$4.52M 929
2018
Q3
$4.52M Buy
50,495
+4,330
+9% +$383K 0.13% 205
2018
Q2
$3.67M Sell
46,165
-3,080
-6% -$256K 0.11% 268
2018
Q1
$4.39M Sell
49,245
-1,130
-2% -$108K 0.14% 207
2017
Q4
$5.26M Sell
50,375
-13,490
-21% -$1.52M 0.16% 183
2017
Q3
$9.31M Sell
63,865
-27,875
-30% -$3.8M 0.29% 85
2017
Q2
$11.9M Buy
91,740
+5,260
+6% +$645K 0.32% 77
2017
Q1
$10.8M Buy
86,480
+51,715
+149% +$6.19M 0.31% 89
2016
Q4
$4.02M Buy
+34,765
New +$3.87M 0.11% 205
2016
Q1
Sell
-4,895
Closed -$586K 719
2015
Q4
$586K Sell
4,895
-3,590
-42% -$415K 0.02% 447
2015
Q3
$918K Buy
8,485
+6,415
+310% +$796K 0.03% 379
2015
Q2
$240K Sell
2,070
-91,225
-98% -$10.4M 0.01% 429
2015
Q1
$10.8M Sell
93,295
-2,980
-3% -$356K 0.29% 104
2014
Q4
$10.8M Buy
96,275
+88,985
+1,221% +$9.38M 0.29% 100
2014
Q3
$690K Sell
7,290
-20,700
-74% -$1.87M 0.02% 291
2014
Q2
$2.4M Sell
27,990
-223,070
-89% -$17M 0.06% 206
2014
Q1
$17.5M Buy
251,060
+30,660
+14% +$2.43M 0.48% 74
2013
Q4
$18.6M Sell
220,400
-10,320
-4% -$817K 0.56% 62
2013
Q3
$17.8M Sell
230,720
-14,320
-6% -$1M 0.55% 62
2013
Q2
$14.3M Buy
+245,040
New +$14.7M 0.45% 73

Other funds holding CELG

Chicago Equity Partners's CELG Position: Q4 2019 in Review

Chicago Equity Partners sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 23,035 shares — an estimated $2.29M sold.

Chicago Equity Partners first reported a position in CELG in Q2 2013 and held it in 20 quarters. The position peaked at $18.6M in Q4 2013. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Chicago Equity Partners reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Chicago Equity Partners sold 23,035 Celgene Corp shares in Q4 2019, an estimated $2.29M.
  • Chicago Equity Partners first reported a position in Celgene Corp in Q2 2013 and held it in 20 quarters.
  • Chicago Equity Partners's Celgene Corp position peaked at $18.6M in Q4 2013.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Chicago Equity Partners's 13F filing for Q4 2019, filed 10 Feb 2020.